Furthermore, one patient harbored a duplication in TMTC3 gene which was found to be unregulated in breast cancer associated blood vessels and may therefore constitute a potentially anti-angiogenic target for breast cancer therapy [65]. This evidence concerns the gene TMTC3 and breast cancer.